Brain injury biomarkers are not dependent on β‐amyloid in normal elderly
Objective The new criteria for preclinical Alzheimer disease (AD) proposed 3 stages: abnormal levels of β‐amyloid (stage 1), stage 1 plus evidence of brain injury (stage 2), and...